Water → HCID 57504302, compound
Reaction equation
[H-].[Na+].[NH2:3][C:4]1[S:5][CH:6]=[C:7]([CH3:9])[N:8]=1.[CH2:10]([O:12][CH:13]([S:19][C:20]1[N:25]=[CH:24][N:23]=[C:22]2[N:26]([C:29]3[CH:34]=[CH:33][CH:32]=[CH:31][C:30]=3[O:35][CH3:36])[N:27]=[CH:28][C:21]=12)[C:14](OCC)=[O:15])[CH3:11].O>C1COCC1.C(Cl)Cl>[CH2:10]([O:12][CH:13]([S:19][C:20]1[N:25]=[CH:24][N:23]=[C:22]2[N:26]([C:29]3[CH:34]=[CH:33][CH:32]=[CH:31][C:30]=3[O:35][CH3:36])[N:27]=[CH:28][C:21]=12)[C:14]([NH:3][C:4]1[S:5][CH:6]=[C:7]([CH3:9])[N:8]=1)=[O:15])[CH3:11]Participants
Procedure
Sodium hydride (95%, 3.7 mg, 0.15 mmol) was added to a stirred solution of 2-amino-4-methylthiazol (17.6 mg, 0.154 mmol) in anhydrous THF (4 mL). The reaction mixture was kept at ambient temperature for 5 minutes before ethyl ethoxy{[1-(2-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]thio}acetate (50 mg, 0.129 mmol) was added. The reaction mixture was stirred at ambient temperature for 1 h. Water and DCM were added and the two phases were separated. The organic phase was dried over MgSO4 and concentrated in vacuo. The residue was purified with column chromatography (silica gel, eluting with a gradient consisting of 40-100% EtOAc in heptane) to give the title compound as a colourless oil (1.1 mg), 1H NMR (300 MHz, CDCl3) δ 10.03 (br s, 1H), 8.74 (s, 1H), 8.26 (s, 1H), 7.47 (m, 2H), 7.12 (m, 2H), 6.91 (s, 1H), 6.58 (s, 1H), 4.02 (m, 1H), 3.81 (m, 4H), 2.38 (s, 3H), 1.34 (t, 3H), HRMS: calcd for (M+H+) C20H21N6O3S2: 457.1116. Found: 457.1116.
Workup
- additionwas added
- customthe two phases were separated
- dry with materialThe organic phase was dried over MgSO4
- concentrationconcentrated in vacuo
- customThe residue was purified with column chromatography (silica gel
- washeluting with a gradient
Sources & evidence
- ORD record
- ord-06aa12638dac4caebae2a849f1266563
- Source dataset
- uspto-grants-2012_03
- Patent number
- US08143263B2
Reaction notes
Loading…